CANTEL MEDICAL REPORTS 18% INCREASE IN SALES FOR 2ND QTR 2008.

Cantel Medical Corp. (NYSE:CMN), Little Falls, N.J., reported income from continuing operations of $2,157,000, or $0.13 per diluted share (inclusive of approximately $0.02 of stock-based compensation expense), on an 18% increase in sales to $60,910,000 for the second quarter ended January 31, 2008. This compares with income from continuing operations of $2,252,000, or $0.14 per diluted share (inclusive of approximately $0.01 of stock-based compensation expense), on sales of $51,635,000 for the second quarter ended January 31, 2007. For the six months ended January 31, 2008, the company reported income from continuing operations of $4,096,000, or $0.25 per diluted share (inclusive of $0.04 of stock-based compensation expense), on an 18% increase in sales to $120,915,000. This compares with income from continuing operations of $3,975,000, or $0.25 per diluted share (inclusive of $0.02 of stock-based compensation expense), on sales of $102,119,000 for the six months ended January 31, 2007. According to R. Scott Jones, Cantel's president and CEO, "We were pleased with our continued core revenue growth in the second quarter, as well as the first half of 2008. Our growth in earnings from an EBITDAS1 perspective was 15% (to $8,223,000) for the quarter and 19% (to $16,069,000) for the first half of the year, compared to the same periods last year. We have made significant investments in marketing and sales during the past six months, as well as in recent acquisitions, and anticipate realizing the benefits from these initiatives in the coming quarters.

The company further reported that its balance sheet at January 31, 2008 included current assets of $83,609,000, including cash of $14,208,000, a current ratio of 2.6:1, a ratio of funded debt to equity of .41:1, debt of $66,800,000 and stockholders' equity of $163,784,000.

Cantel Medical Corp. is a leading provider of infection prevention and control products in the healthcare market. Our products include specialized medical device reprocessing systems for renal dialysis and endoscopy, dialysate concentrates and other dialysis supplies, disposable infection control products primarily for the dental industry, water purification equipment, sterilants, disinfectants and cleaners, hollow fiber membrane filtration and separation products for medical and non-medical applications, and specialty packaging for infectious and biological specimens. We also provide technical maintenance for our products and offer compliance training services for the transport of infectious and biological specimens.

For more information, visit http://www.cantelmedical.com or call 973/890-7220.